Preclinical characterization and anti-SARS-CoV-2 efficacy of ATV014: an oral cyclohexanecarboxylate prodrug of 1'-CN-4-aza-7,9-dideazaadenosine C-nucleoside
ATV014（1'-CN-4-氮杂-7,9-二脱氮腺苷C-核苷的口服环己烷羧酸酯前药）的临床前表征及抗SARS-CoV-2疗效
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-023-01310-0
Zhou, Qifan; Yang, Sidi; Cao, Liu; Yang, Yang; Xu, Tiefeng; Chen, Qishu; Lu, Hongzhou; Li, Yingjun; Guo, Deyin; Zhang, Xumu
